HEOR and open access: COO Richard White contributes expertise to ISPOR article

14 April 2021

Share this page

Share this page on LinkedIn

Richard White, COO of Oxford PharmaGenesis, provides his expert insights on health economics and outcomes research (HEOR) publications and open access in a new article from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading global professional society for HEOR.

Featured in the ISPOR publication Value & Outcomes Spotlight, ‘Navigating the Changing HEOR Publishing Landscape’ examines the impact on publishing of the growth of HEOR and the drive towards open access. Richard was interviewed for the article alongside other leaders in this field, including Johan Rooryck, Executive Director of cOAlition S, and Michael Drummond, former President of ISPOR. The invitation from ISPOR to contribute to this article recognizes Oxford PharmaGenesis’ leadership role in HEOR communications and open access, through the work of our Value Demonstration Practice and Open Pharma – our collaborative initiative driving positive change in the communication of pharma-sponsored research.

Read the article here.